Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
40 studies found for:    Open Studies | "Duodenal Diseases"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Duodenal Diseases"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Endoscopic Characteristics of Duodenal and Ampullary Lesions
Condition: Duodenal Diseases
Intervention: Other: Tissue Sampling
2 Recruiting UI-EWD for Endoscopic Hemostasis of Bleeding Peptic Ulcers and Bleeding After EMR/ESD
Condition: Peptic Ulcer
Interventions: Procedure: endoscopic adhesive powder;   Drug: epinephrine;   Device: Endoscopic Wound Dressing (Next Biomedical)
3 Not yet recruiting The Pilot Study on Tailored Eradication Therapy According to Clarithromycin Resistance in H.Pylori Patients
Condition: Peptic Ulcer
Interventions: Drug: Ilaprazole;   Drug: Amoxicillin;   Drug: Clarithromycin;   Drug: Metronidazole
4 Recruiting Effect of Second-look Endoscopy on Peptic Ulcer Rebleeding in Patients With Early Resumption of Antiplatelet Agents
Conditions: OGD;   Gastric Ulcer Induced by Anti-platelet Agent;   Duodenal Ulcer Induced by Anti-platelet Agent
Interventions: Procedure: Second-look OGD;   Drug: Esomeprazole
5 Recruiting A Study to Compare the Pharmacokinetics of Lafutidine and Irsogladine Maleate Tablet
Condition: Gastric Ulcer
Interventions: Drug: BRI-1501;   Drug: Lafutidine;   Drug: Irsogladine maleate
6 Recruiting Domestic Surgical Robot Clinical Study
Condition: Gastric Ulcer With Perforation But Without Obstruction,
Intervention: Procedure: robotic surgery
7 Recruiting Proton Pump Inhibitor Versus Histamine-2 Receptor Antagonist for the Prevention of Recurrent Peptic Ulcers
Condition: Peptic Ulcer
Interventions: Drug: proton pump inhibitor (PPI) group pantoprazole;   Drug: histamine-2 receptor antagonist group famotidine
8 Recruiting Efficacy of H2 Receptor Antagonist in Prevention of Thienopyridine-related Peptic Ulcer
Condition: Peptic Ulcer
Interventions: Drug: histamine-2 receptor antagonist (famotidine);   Drug: Placebo
9 Recruiting Efficacy and Safety of PMK-S005 in the Prevention of Recurrent Peptic Ulcer in Low-dose Aspirin Users
Condition: Peptic Ulcer
Interventions: Drug: Placebo;   Drug: PMK-S005 1;   Drug: PMK-S005 2;   Drug: PMK-S005 3
10 Recruiting DLBS2411 Treatment for Ulcer Healing in Non-Bleeding Peptic Ulcers
Condition: Non-Bleeding Peptic Ulcers
Interventions: Drug: Omeprazole;   Drug: Placebo caplet of DLBS2411;   Drug: DLBS2411;   Drug: Placebo capsule of Omeprazole
11 Recruiting Urgent vs. Early Endoscopy in High Risk Patients With Upper Gastrointestinal Bleeding (UGIB)
Conditions: Bleeding Peptic Ulcer;   Active Bleeding;   Gastrointestinal Bleeding
Interventions: Other: Urgent endoscopy;   Other: Early endoscopy
12 Recruiting PPI vs H2RA in Patients With Helicobacter Pylori-Negative Idiopathic Bleeding Ulcers
Condition: Peptic Ulcer
Interventions: Drug: Lansoprazole;   Drug: Famotidine
13 Recruiting Effect of ALBIS on Gastroduodenal Mucosal Injury in Patients Receiving Dual Antiplatelet Therapy After Percutaneous Coronary Intervention
Conditions: Gastritis;   Gastroduodenal Ulcer
Interventions: Drug: ALBIS;   Drug: Placebo
14 Recruiting Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Clarithromycin Quadruple Therapy
Conditions: Gastritis;   Peptic Ulcer;   Dyspepsia
Interventions: Drug: Berberine;   Drug: clarithromycin;   Drug: Bismuth;   Drug: Lansoprazole;   Drug: amoxicillin
15 Recruiting Frequent Ketamine Use and Gastrointestinal, Liver and Biliary Sequelae
Conditions: Gastritis;   Peptic Ulcer Disease;   Cholangiopathy;   Liver Fibrosis
Intervention:
16 Recruiting Comparison of Low Against High Regimen of Proton Pump Inhibitors for Treatment of Acute Peptic Ulcer Bleeding
Conditions: Gastroduodenal Ulcer;   Marginal Ulcer;   Peptic Ulcer Hemorrhage
Interventions: Drug: Omeprazole High dose;   Drug: Omeprazole Low dose
17 Not yet recruiting A Multi-center Study for Individual Treatment of Helicobacter Pylori Infection
Conditions: Gastritis;   Gastric Ulcer
Interventions: Biological: Antibiotic selection based on the antibiotic susceptibility testing;   Genetic: PPI selection based on the CYP2C19 gene polymorphism;   Dietary Supplement: Probiotics usage based on the 16SrRNA sequencing
18 Recruiting Long-term Oral Esomeprazole for Prevention of Peptic Ulcer Rebleeding in High-risk Patients
Condition: Peptic Ulcer Hemorrhage
Interventions: Drug: oral esomeprazole 20 mg twice daily;   Drug: oral esomeprazole 20 mg once daily
19 Recruiting Doppler-guided Endoscopic Treatment in Peptic Ulcer Bleeding
Condition: Peptic Ulcer Bleeding
Interventions: Device: Supplementary endoscopy with doppler-guided therapy;   Drug: IV. PPI;   Other: Endoscopic treatment at primary endoscopy
20 Recruiting Second-look Endoscopy in High Risk Patients After Endoscopic Hemostasis to Their Bleeding Peptic Ulcers Improves Their Outcomes
Condition: Ulcer Bleeding
Interventions: Procedure: epinephrine injection or heater probe or hemoclips;   Other: Observation only

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.